These data suggested that miR‐1184 inhibitor enhanced the phenotypes of CRC cells via releasing AJUBA to inactivate the Hippo/YAP signalling pathway (a schematic mechanism illustration is presented in Figure 8C). The gene discussed is AJUBA; the disease is colorectal carcinoma.